The recent approval of AstraZeneca’s Imfinzi as the first-line treatment for biliary tract cancer signaled a new turning point because it was the first immunotherapy to score the nod in bile duct cancer, an expert said. AstraZeneca Korea on Tuesday held a press conference celebrating the Korean appr
A local analyst said investors should pay attention to Yuyu Pharmaceutical's new drugs.In a report published on Monday, IBK Securities analyst Chae Yun-seok introduced two new drugs – YP-P10 and YY-DUT -- under development by Yuyu."Yuyu Pharmaceutical is developing YP-P10, which is indicated for dry
Boryung said on Tuesday that it signed an exclusive domestic sales contract with German pharmaceutical company, Cheplapharm, for Taxol (ingredient: paclitaxel).Taxol is an original paclitaxel drug, developed by Bristol Myers Squibb (BMS). Its alkaloid anticancer formulation treats various carcinoma
GI Innovation, a Korean developer of allergy drugs and immunotherapy, said Tuesday it has submitted a registration statement to the Financial Services Commission and initiated the initial public offering (IPO) procedure.The company plans to offer 2 million depository receipts at 16,000-21,000 won ($
Despite the Korean stock market’s bullish rally at the beginning of the new year, biopharmaceutical stock prices remained sluggish because of no tangible results from licensing-out deals, analysts said.According to the Korea Exchange, the KRX300 Healthcare Index calculated by the Korea Exchange from
Kolmar Korea is reportedly considering establishing a second plant for manufacturing skincare products in the U.S. following the construction plans to build an artificial intelligence (AI)-backed cosmetics plant in Sejong.According to the local news media Chosun Biz on Monday, Kolmar Korea is intern
JW Pharmaceutical said on Monday that it would develop raw materials for new drug candidates with Merck Life Science using an artificial intelligence (AI) platform based on a mutual business agreement.Under the agreement, Merck will provide its AI software, SYNTHIA, to JW Pharmaceutical and provide
Boryung (former Boryung Pharmaceutical) said Friday it plans to release in Korea Zepzelca (lurbinectedin), a new small cell lung cancer (SCLC) treatment developed by Spanish company PharmaMar S.A., in March.Expectations are high for expanding treatment options amid limited secondary treatments for s
The Korean biopharmaceutical industry has continued to show its R&D prowess in January with multiple license deals.Considering that Korean biopharmaceutical companies signed only 16 license contracts in 2022, the deals made in January accounted for a quarter of last year’s total.According to the Kor
Yonsei University Health System (YUHS) and Korea International Cooperation Agency (KOICA) said they successfully completed the maternal and child health capacity building project in Senegal. KOICA is a n official development assistance (ODA) unit under the Ministry of Foreign Affairs.The program, wh
Bridge Biotherapeutics said on Thursday that it signed a memorandum of understanding (MOU) with Pinotbio to derive new therapeutic cancer candidates using antibody-drug conjugate (ADC) platform technology.Accordingly, Bridge Biotherapeutics will provide private anticancer targets, and Pinotbio will
As the government moves toward expanding insurance coverage for atopic dermatitis from adult to children and adolescent patients, negotiation will likely speed up to give benefits to injections and pills.For example, Sanofi is bargaining with the National Health Insurance Service (NHIS) to determine
Abion said on Wednesday that a joint animal study with Raphas to develop its Covid-19 DNA vaccine based on portable electro-attached microneedle patches under the support of the RIGHT Foundation’s technical acceleration award (TAA), has attained the first milestone showing strong antibody titers.As
Kolmar Korea said it would build an AI-backed mega plant in Sejong by 2024 to manufacture about 220 million units of cosmetics products annually to meet the growing global demand.The move comes as the Covid-19 pandemic is quickly becoming endemic worldwide and the global demand for makeup products,
Samil Pharmaceutical said on Wednesday that it launched Samsung Bioepis’ Amelivu (ingredient: Ranibizumab), a Lucentis biosimilar to treat macular degeneration, in Korea.Both companies had signed a domestic distribution and sales contract for Amelivu in June 2022. Amelivu is an ophthalmic disease tr
The supply price of all over-the-counter Tylenol (ingredient: acetaminophen) products sold at pharmacies and convenience stores will increase by about 18 percent.According to industry watchers, Johnson & Johnson Korea sent an official letter to pharmaceutical distributors regarding a price hike for
As the Ministry of Health and Welfare announced a list of newly certified “innovative pharmaceutical companies” companies for 2023, attention is drawn to new additions.On Thursday, the ministry said in a public notice that it had designated four more companies – Bridge Biotherapeutics, GI Innovation
SK Bioscience is recruiting executives from multinational pharmaceutical companies ahead of its full-scale overseas business expansion.The company said Friday it has recruited Richard Kensinger, a former research executive at global healthcare company Sanofi Pasteur, as the vice president of R&D pro
Medytox said on Friday that Gentix Limited, a subsidiary of its Chinese business partner Bloomage Biotechnology, filed a claim for damages against Medytox for contract violation with the Singapore International Arbitration Center (SIAC).According to Medytox’s public filing on Friday, the claim amoun
LG Chem said on Thursday that it invested 707.2 billion won ($571 million) to complete the acquisition of Aveo Pharmaceuticals, a U.S. oncology-specializing biopharma firm, through LG Chem Life Science Innovation Center, and will finalize the last details of the merger on Friday this week.The compan